In a news release quietly published June 29, 2022, the U.S. Department of Health and Human Services announced that it, in partnership with the Department of Defense, agreed to purchase another 105 million doses of Pfizer’s COVID-19 shot — for $ 3.2 billion.1 The contract is intended to supply shots for a coming fall injection… Read More »
Loading the player… Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 in what would be a major expansion that could combat an alarming rise in serious infections in youngsters and help schools stay open. If regulators give the go-ahead, reduced-dose kids’ shots could begin… Read More »
Breadcrumb Trail Links News Health Canada The Johnson & Johnson vaccine is approved, but Canada hasn’t been using it. Some say the viral vector shot could convince more people to get vaccinated Author of the article: Sharon Kirkey Publishing date: Oct 01, 2021 • 2 days ago • 5 minute read • 285 Comments A Johnson… Read More »
The Coronavirus Outbreak Covid-19 Updates Coronavirus Map and Cases Delta Variant Pandemic Relief Programs Ending What is HIPAA? Advertisement Continue reading the main story Supported by Continue reading the main story Israeli Data Suggests Possible Waning in Effectiveness of Pfizer Vaccine The new numbers still show overwhelmingly strong protection against severe disease but diminished effectiveness against… Read More »
FRIDAY, July 16, 2021 — Pfizer Inc. announced on Friday that the U.S. Food and Drug Administration has granted priority review to its COVID-19 vaccine, positioning the vaccine for full approval by January. The Pfizer vaccine has been administered to more Americans than any other shot so far in the U.S. vaccination campaign. According to… Read More »
Loading the player… The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year. The announcement is set to… Read More »
WEDNESDAY, April 28, 2021 — Only 13.5% of people will suffer systemic side effects after getting Pfizer’s coronavirus vaccine, a new study finds. These systemic symptoms include headache, fatigue and tenderness. Most side effects are mild and peak in the day after being vaccinated, and they only last for one to two days, according to… Read More »